Phibro Animal Health Corporation (PAHC) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Total Cash From Operating Activities Chart for Phibro Animal Health Corporation

Phibro Animal Health Corporation (PAHC) operating cash flow for FY2026 was USD 69.0M, a -13.9% change from FY2025. Phibro Animal Health Corporation's operating cash flow moved from USD -7.9M in 2000 to USD 69.0M in 2026 over 26 years. Operating cash flow compound annual growth rate: 5-year CAGR of 7.4%, 10-year CAGR of 6.4%, 20-year CAGR of 17.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.58B
Implied Share Price
$74.68
Enterprise Value
$2.09B
Revenue (TTM)
$1.52B
EBITDA
$244.23M
Profit Margin
6.57%
Trailing P/E
15.98
Forward P/E
13.83
Price/Book (MRQ)
3.59
Price/Sales (TTM)
1.04
EV/EBITDA
8.98
EV/Revenue
1.38
Dividend Yield
1.26%
Book Value
$9.50
Free Cash Flow (FY2026)
$9.87M
Free Cash Flow Yield
0.63%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.